Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), an
international leader in sustainable bioprotection and plant health
solutions, announced today that its 2019 field trial results for
biology-based seed treatments in Europe demonstrated improved
yields and cost-effective control of soil insects and nematodes
that are equivalent to or better than current industry
standards.
Additionally, the company’s wholly owned subsidiary, Pro Farm
Technology OY (Pro Farm), has demonstrated significant benefits to
growers when its patented Foramin® nutrient technology is used in
conjunction with conventional or biology-based seed
treatments. Foramin offers growers enhanced plant physiology,
reduced plant stress, and improved yields and crop quality.
Results from recent yield and stress tolerance trials will be
presented by Kalle Virta, director of research and development for
Pro Farm, at the “Exceed The Seed” event during the American Seed
Trade Association meeting on December 9, 2019 in Chicago,
Illinois.
“The past growing season marked our first international tests —
including in the European Union — of the Marrone Bio suite of seed-
and soil-applied products,” said Chief Commercial Officer Kevin
Hammill. “These bioprotection products complement Pro Farm’s
existing portfolio of plant health products. With Pro Farm’s broad
international distribution capabilities, we expect to bring to more
growers the benefits of MBI’s technology and broad bioprotection
product portfolio.”
Marrone Bio’s and Pro Farm’s family of seed and soil treatment
products are currently available to growers through its
distribution and seed company partners in the United States,
Canada, Uruguay and Europe with near term expansion into India,
Australia, Brazil, Argentina, Paraguay, Bolivia and CIS region for
use in a wide variety of crops including corn, soybean, cotton,
wheat, barley, sunflower, oilseed rape and vegetables.
MBI European Seed Treatment Field Trial
Results
Corn seed treatment trials testing MBI-203 and MBI-206 for corn
root worm and nematode control showed yield gains against both the
untreated control and a currently used chemical option. When
compared with the current treatment, yield gains as high as 35
percent were observed when used at commercial application
rates.
Pro Farm Stress-Tolerance Greenhouse and Field Trial
Results
Pro Farm tested its Foramin products for 18 different stress
parameters across multiple growth stages for barley and wheat in
both greenhouse and field conditions in Europe throughout
2019. Foramin is designed to be used in combination with a
standard conventional seed treatment package. The Foramin
products include both a seed treatment and a foliar applied
product.
Last season’s results from barley and wheat field trials in
Latin America showed yield increases in barley ranging from 2.1
percent to 6.7 percent; and in wheat from 9.0 percent to 14.3
percent. At current commodity prices, these yield gains would
add approximately $8 to $26 per acre in revenue for barley growers,
and approximately $44 to $68 per acre in revenue for wheat
growers.
About Marrone Bio
Innovations Marrone Bio
Innovations Inc. (NASDAQ: MBII) is a growth-oriented company
leading the movement to a more sustainable world through the
discovery, development and sale of innovative biological products
for crop protection, plant health and waterway systems treatment
that help customers operate more sustainably while increasing their
return on investment. MBI has screened over 18,000 microorganisms
and 350 plant extracts, leveraging its in-depth knowledge of plant
and soil microbiomes enhanced by advanced molecular technologies
and natural product chemistry to rapidly develop seven product
lines. Supported by a robust portfolio of over 400 issued and
pending patents, MBI’s currently available commercial products are
Regalia®, Stargus®, Grandevo®, Venerate®, Majestene®, Haven® and
Amplitude®, Zelto® Jet Oxide® and Jet Ag® and Zequanox®, with a
breakthrough bioherbicide and biofumigant in the Company’s product
pipeline. MBI also recently completed the acquisition of Pro Farm
Finland-based Pro Farm’s technology employs a proprietary
technology derived from wood waste to stimulate plant growth and
improve plant health, resulting in improved yields and crop
quality.
Learn more about Marrone Bio Innovations at
www.marronebio.com. We also use our investor relations website,
https://investors.marronebio.com, as well as our corporate Twitter
account, @Marronebio, as means of disclosing material non-public
information, and encourage our investors and others to monitor and
review the information we make public in these locations. Follow us
on social media: Twitter, LinkedIn and Instagram.
Marrone Bio Innovations Forward Looking
StatementsThis press release contains forward-looking
statements that involve substantial risks and uncertainties. All
statements, other than statements of historical facts, included in
this press release regarding strategy, future operations and plans,
including assumptions underlying such statements, are
forward-looking statements, and should not be relied upon as
representing MBI’s views as of any subsequent date. Such
forward-looking statements are based on information available to
the Company as of the date of this release and involve a number of
risks and uncertainties, some beyond the Company’s control, that
could cause actual results to differ materially from those
anticipated by these forward-looking statements, including hiring
new leadership, the potential of new revenue generating activities,
field trial results weather, regulatory and other factors affecting
demand for the MBI’s products, any difficulty in marketing MBI’s
products in its target markets, competition in the market for pest
management products, lack of understanding of bio-based pest
management products by customers and growers. Additional
information that could lead to material changes in MBI’s
performance is contained in its filings with the SEC. MBI is under
no obligation to, and expressly disclaims any responsibility to,
update or alter forward-looking statements contained in this
release, whether as a result of current information, future events
or otherwise.
Marrone Bio Innovations Contacts:Kevin Hammill,
Chief Commercial OfficerMatti Tainen, Managing Director, Pro Farm
Technologiesinfo@marronebio.com1-530-750-2800
Investor Relations Contact:Greg Falesnik,
Managing DirectorMZ Group – MZ North AmericaMain:
949-385-6449MBII@mzgroup.uswww.mzgroup.us
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/ac047212-6374-4a0f-b575-83f62408fcf0
Marrone Bio Innovations (NASDAQ:MBII)
Historical Stock Chart
From Aug 2024 to Sep 2024
Marrone Bio Innovations (NASDAQ:MBII)
Historical Stock Chart
From Sep 2023 to Sep 2024